De novo gene design is a transformative approach in synthetic biology that enables the creation of entirely new gene sequences from scratch. This chapter explores the principles, methodologies, and applications of de novo gene design, with a focus on its roles in synthetic biology, drug discovery, and biotechnology. The field has advanced significantly through the integration of high-throughput screening, computational biology, and data-driven design using artificial intelligence (AI) and machine learning (ML) to optimize genetic sequences and predict functionality with greater accuracy. The design-to-validation pipeline involves computational modeling for sequence design, experimental gene expression testing, and iterative optimization through directed evolution to enhance protein yield and function. Key considerations such as cloning strategies, vector systems, and the selection of regulatory elements are discussed in the context of maximizing gene expression across various host organisms. Additionally, the chapter emphasizes the importance of addressing ethical implications, biosafety, and the need for rigorous large-scale validation to ensure the responsible use of synthetic genes. Looking forward, continued advances in AI, ML, and computational tools hold immense potential to accelerate innovation in areas such as biofuel production, biopharmaceutical development, and sustainable biotechnologies.